NCT02342730View on ClinicalTrials.gov

Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia

NACompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

December 17, 2014

Primary Completion Date

May 18, 2015

Study Completion Date

May 18, 2015

Conditions

Complex Endometrial Hyperplasia With AtypiaStage IA Uterine Corpus CancerStage IB Uterine Corpus CancerStage II Uterine Corpus Cancer

Interventions

BEHAVIORAL

Weight Loss Specialist

Referred to a weight loss specialist

OTHER

Quality-of-Life Assessment

Complete EORTC-QLQ questionnaires

OTHER

Medical Chart Review

Chart reviews are performed

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT02342730 - Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia | Biotech Hunter | Biotech Hunter